SCHEMBL282326

SCHEMBL282326

O=C1COc2cc([N+](=O)[O-])ccc2N1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.51
MAPT P10636 2/20 0.51
ALDH1A1 P00352 3/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CYP11B1 P15538 1/20 0.47
CYP11B2 P19099 1/20 0.47
PGR P06401 3/20 0.46
NR3C1 P04150 2/20 0.46
AR P10275 2/20 0.46
CAPN9 O14815 1/20 0.46
CASP3 P42574 1/20 0.46
MMP12 P39900 1/20 0.46
NR3C2 P08235 1/20 0.46
GAA P10253 1/20 0.46
LMNA P02545 1/20 0.44
HPGD P15428 1/20 0.44
PDE4D Q08499 1/20 0.44
RAF1 P04049 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30806805 1.00 POLB (0.51) POLBMAPTALDH1A1MEN1KMT2A
SCHEMBL31490264 0.88 MAPT (0.60) POLBMAPTALDH1A1KMT2AMMP12
SCHEMBL304014 0.88 MAPT (0.60) POLBMAPTALDH1A1KMT2AMMP12
SCHEMBL28564407 0.85 MEN1 (0.46) POLBMAPTALDH1A1MEN1KMT2A
SCHEMBL4577576 0.83 NR3C1 (0.48) POLBMAPTALDH1A1MEN1KMT2A
SCHEMBL8139811 0.80 NR3C1 (0.43) POLBMAPTALDH1A1MEN1KMT2A
SCHEMBL9377316 0.79 CYP3A4 (0.55) POLBMAPTALDH1A1MEN1KMT2A
SCHEMBL29946473 0.77 MAPT (0.46) POLBMAPTALDH1A1MEN1KMT2A
SCHEMBL13932063 0.76 NR3C2 (0.54) POLBMAPTALDH1A1MEN1KMT2A
SCHEMBL4263148 0.76 NR3C2 (0.54) POLBMAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 203 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4561561-A2 SUBSTITUTED 3,4-DIHYDROQUINOLINONE INHIBITORS OF TSHR Septerna, Inc. (US) 2025-06-04 EP disclosed
WO-2025096710-A1 MODULATORS OF BCL6 AS LIGAND DIRECTED DEGRADERS BRISTOL-MYERS SQUIBB COMPANY (US) 2025-05-08 WO disclosed
EP-4384267-A1 SMALL MOLECULE STING ANTAGONISTS Curadev Pharma Pvt. Ltd. (IN) 2024-06-19 EP disclosed
CN-118159535-A Small molecule STING antagonists 库拉德夫制药私人有限公司 2024-06-07 CN disclosed
WO-2024026076-A2 SUBSTITUTED 3,4-DIHYDROQUINOLINONE INHIBITORS OF TSHR SEPTERNA, INC. (US) 2024-02-01 WO disclosed
WO-2023017451-A1 SMALL MOLECULE STING ANTAGONISTS CURADEV PHARMA PVT. LTD. (IN) 2023-02-16 WO disclosed
US-11091488-B2 1-cyano-pyrrolidine derivatives as inhibitors of USP30 MISSION THERAPEUTICS LIMITED (GB) 2021-08-17 US disclosed
US-11084784-B2 ROR-gamma modulators and uses thereof Piramal Enterprises Limited (IN) 2021-08-10 US disclosed
CN-111196817-B Tricyclic compounds as BRPF1 inhibitors 四川大学华西医院 2021-06-11 CN disclosed
US-20200262838-A1 1-CYANO-PYRROLIDINE DERIVATIVES AS INHIBITORS OF USP30 MISSION THERAPEUTICS LIMITED (GB) 2020-08-20 US disclosed
US-5118323-A Hair dyes CLAIROL, INC. 1992-06-02 US disclosed
WO-1992004345-A1 6- or 7- (2-IMINO-2-IMIDAZOLIDINE)-1,4-BENZOXAZINES AS ALPHA ADRENERGIC AGENTS ALLERGAN, INC. (US) 1992-03-19 WO disclosed
US-5091528-A Antiglaucoma, antidiarrhea agents, diuretics, vasoconstrictors ALLERGAN, INC. (US) 1992-02-25 US disclosed
US-5077401-A Herbicides NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1991-12-31 US disclosed
US-5055110-A Hair dyes CLAIROL INCORPORATED (US) 1991-10-08 US disclosed
WO-1991007394-A1 BENZOXAZINE DYES BRISTOL-MYERS SQUIBB COMPANY (US) 1991-05-30 WO disclosed
US-4902335-A Benzo-fused cyclic compounds NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1990-02-20 US disclosed
US-4798620-A Benzoxazines and herbicidal use NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1989-01-17 US disclosed
EP-0296416-A1 Benzo-anellated cyclic compounds NIHON BAYER AGROCHEM K.K. (JP) 1988-12-28 EP disclosed
EP-0290863-A2 Benzoxazine derivative, process and intermediates for its preparation and its use as herbicide NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1988-11-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11091488-B2 1-cyano-pyrrolidine derivatives as inhibitors of USP30 USP30, USP1, USP20 POLB 752/4885MAPT 2689/4885ALDH1A1 787/4885
US-11084784-B2 ROR-gamma modulators and uses thereof RORB, RORA, RORC POLB 2686/4885MAPT 251/4885ALDH1A1 902/4885
US-20200262838-A1 1-CYANO-PYRROLIDINE DERIVATIVES AS INHIBITORS OF USP30 USP30, USP1, USP20 POLB 752/4885MAPT 2689/4885ALDH1A1 787/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.